|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.29 USD | +1.57% |
|
-3.37% | -31.38% |
| 05-15 | HC Wainwright Adjusts IO Biotech Price Target to $12 From $8, Maintains Buy Rating | MT |
| 05-14 | IO Biotech, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
IO Biotech, Inc. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported net loss was USD 19.46 million compared to USD 17.04 million a year ago. Basic loss per share from continuing operations was USD 0.3 compared to USD 0.59 a year ago.
Diluted loss per share from continuing operations was USD 0.3 compared to USD 0.59 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -31.38% | 84.99M | |
| +54.05% | 58.71B | |
| -2.02% | 41.31B | |
| +37.40% | 39.2B | |
| -10.22% | 27.4B | |
| +13.42% | 26.55B | |
| -21.60% | 18.98B | |
| +2.89% | 12.51B | |
| +22.40% | 11.94B | |
| +27.49% | 12.08B |
IO BIOTECH, INC. 
